Diagnostic firms such as Dr Lal PathLabs, Thyrocare Technologies and Metropolis Healthcare rebound as COVID-19 related tests drive business growth. While non COVID-19 business is showing signs of normalisation, sustainability of recovery is key
Diagnostics company Thyrocare Technologies felt the blow of demonetisation in the month of November but was back on its feet and saw growth at 24 percent in the month under review.
MedGenome having presence in USA, India and Singapore, offers genomics solutions in cancer immunotherapy and diabetes and works with various commercial and academic researchers globally on genomic research projects.